Ondansetron Tablet, Orally Disintegrating
Product Images NDC 60760-654

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 60760-654). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ondansetron (Ondansetron 654 10)

Ondansetron 4 mg orally disintegrating tablets, USP, in a 10-count package. The label shows the product name, strength, dosage form, quantity, and manufacturer information: Glenmark Pharmaceuticals Inc., USA, with packaging by St. Mary's Medical Park Pharmacy in Oro Valley, AZ. The label includes space for RX number, lot number, and expiration date, along with storage instructions at controlled room temperature.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure-base (Structure Base)

Chemical structure of Ondansetron, the active ingredient shown in the product data. The diagram depicts the molecular structure including a fused bicyclic ring, a ketone functional group, and a methylated imidazole moiety.*

FDA Label Image

Structure-hcl (Structure HCl)

Chemical structure of Ondansetron hydrochloride dihydrate, showing the molecular arrangement of its indole, piperidine, and heterocyclic rings with attached methyl group and hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.